Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Favorite
Like
Tweet
Print
Jennett Chenevert Aijala, Ph.D.
Stoke Therapeutics, Inc.
Poster(s):
(M1130-06-40) Development and Validation of a Sensitive Hybridization-Electrochemiluminescence (H-ECL) Method for Quantitation of STK-002, an Antisense Oligonucleotide, in Human Serum
Monday, October 23, 2023
11:30 AM – 12:30 PM
ET
